Predictors of recurrent stroke in African Americans

Neurology

Volumn 67, Issue 4, 2006, Pages 567-571

  Ruland, S ^a   Richardson, D ^a,b   Hung, E ^a   Brorson, J R ^c   Cruz Flores, S ^d   Felton III, W L ^e   Ford Lynch, G ^f   Helgason, C ^c,g   Hsu, C ^c,g   Kramer, J ^h   Mitsias, P ⁱ   Gorelick, P B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LAKE FOREST COLLEGE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h MERCY HOSPITAL AND MEDICAL CENTER   (United States)

ⁱ HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISABILITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RECURRENT DISEASE; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE;

ACTIVITIES OF DAILY LIVING; AFRICAN AMERICANS; CEREBROVASCULAR ACCIDENT; DISABILITY EVALUATION; FEMALE; HUMANS; INCIDENCE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 33747680305     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000232738.02278.28     Document Type: Article

References (15)

1. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004;35:426-431.
2. Qureshi AI, Suri MFK, Guterman LR, et al. Ineffective secondary prevention in survivors of cardiovascular events in the U.S. population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2001;161:1621-1628.
3. Ruland S, Raman R, Chaturvedi S, et al.for the AAASPS Investigators. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology 2003;60:64-68.
4. Gorelick PB, Richardson D, Kelly M, et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-2957.
5. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;279:1265-1272.
6. The Fifth Report of the Joint National committee on Hypertension (JNC V). Arch Intern Med 1993;153:154-183.
7. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care 1997;20(suppl 1):S1-S70.
8. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
9. NHLBI Obesity Task Force. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6:51S-209S.
10. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
11. Vickrey BG, Rector TS, Wickstrom SL, et al. Occurrence of secondary ischemic events among persons with atherosclerotic disease. Stroke 2002;33:901-906.
12. Bruno A, Biller J, Adams HP Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Neurology 1999;52:280-284.
13. Sacco RL, Shi T, Zamanillo MC, et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-634.
14. Ruland S, Gorelick PB. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? Curr Neurol Neurosci Rep 2003;3:21-26.
15. Ruland S, Hung E, Richardson D, et al. Impact of obesity and the metabolic syndrome on risk factors in African American stroke survivors: a report from the AAASPS. Arch Neurol 2005 62:386-390.